Offer - Urjas Oil for just ₹ 1
Renicol P, a prescription drug, is manufactured in various forms such as Drops. Secondary and off-label uses of Renicol P have also been mentioned below.
The optimal dosage of Renicol P is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Renicol P can also lead to other problems, which have been listed below. Usually, these side effects of Renicol P go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Renicol P is Severe for pregnant women and Severe for women who are breastfeeding. Further, the section on Renicol P related warnings talks about Renicol P's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Kidney Disease, Kidney Disease, Liver Disease must refrain from the use of Renicol P since this can cause severe adverse effects. The section on Renicol P contraindications lists all such conditions.
Drug interactions for Renicol P have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Renicol P, it is important to know that it is safe while driving, and is habit-forming.
Renicol P is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Renicol P safe for pregnant women?
Pregnant women may get severe side effects after taking Renicol P. If you are pregnant, do not take Renicol P without a doctor's advice.
Is the use of Renicol P safe during breastfeeding?
Renicol P should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Renicol P on the Kidneys?
Renicol P rarely affects the kidneys.
What is the effect of Renicol P on the Liver?
You may experience side effects on your liver after taking Renicol P. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Renicol P on the Heart?
The heart can be affected by Renicol P. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Renicol P should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Renicol P unless your doctor advises you to do so -
Is this Renicol P habit forming or addictive?
No, there is no any evidence that Renicol P is addictive.
Interaction between Food and Renicol P
When consumed with certain foods, Renicol P may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Renicol P
Information about the interaction of Renicol P and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Polymyxin B
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 759
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Chloromycetin sodium succinate (chaloramphenicol sodium succinate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 739-742